Glucose metabolism outcomes in acromegaly patients on treatment with pasireotide-LAR or pasireotide-LAR plus Pegvisomant

INTRODUCTION: Disorders of glucose metabolism are a serious acromegaly comorbidity and may be differently impacted by medical treatments of acromegaly. In this retrospective longitudinal multicenter study, we investigated the outcome of glucose metabolism and its predictors in patients treated with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Endocrine
Autors principals: Chiloiro, Sabrina, Giampietro, Antonella, Visconti, Felicia, Rossi, Laura, Donfrancesco, Federico, Fleseriu, Cara M., Mirra, Federica, Pontecorvi, Alfredo, Giustina, Andrea, Fleseriu, Maria, De Marinis, Laura, Bianchi, Antonio
Format: Artigo
Idioma:Inglês
Publicat: Springer US 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8325668/
https://ncbi.nlm.nih.gov/pubmed/33907985
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-021-02711-3
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars